Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-15 Sale | 2023-11-17 4:01 pm | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Former EVP, CFO, & Director | 50,000 | $0.65 | $32,500 | 55 (Direct) | View |
| 2023-06-20 Purchase | 2023-06-20 8:15 pm | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO | 50,000 | $0.97 | $48,500 | 50,055 (Direct) | View |
| 2021-07-02 Sale | 2021-07-07 4:29 pm | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 107,497 | $5.58 | $599,833 | 0 (Direct) | View |
| 2021-06-22 Purchase | 2021-06-24 4:15 pm | ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer | 4,666 | $15 | $69,990 | 4,666 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-11 Option Award | 2024-11-12 4:50 pm | N/A 2034-11-11 | Altimmune Inc. | ALT | WEAVER GREGORY L Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 09:00 am | N/A 2033-06-01 | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO | 2,600,000 | $0 | 2,600,000 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-05 7:36 pm | N/A 2033-05-04 | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-05-13 Option Award | 2022-05-16 6:19 pm | N/A 2032-05-13 | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 3:56 pm | N/A 2032-03-01 | ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer | 228,000 | $0 | 228,000 (Direct) | View |
| 2021-07-02 Exercise | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 164,581 | $0 | 0 (Direct) | View |
| 2021-07-02 Exercise | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 45,000 | $2.52 | 0 (Direct) | View |
| 2021-07-02 Exercise | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 4,581 | $5.64 | 0 (Direct) | View |
| 2021-07-02 Tax Withholding | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 57,084 | $6.4 | 0 (Direct) | View |
| 2021-07-02 Exercise | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 45,000 | $2.38 | 0 (Direct) | View |
| 2021-07-02 Exercise | 2021-07-07 4:29 pm | N/A N/A | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 70,000 | $1.7 | 0 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-22 4:20 pm | N/A 2031-06-17 | ATAI Life Sciences N.V. | ATAI | WEAVER GREGORY L Chief Financial Officer | 67,726 | $0 | 67,726 (Direct) | View |
Ownership | 2021-06-17 6:08 pm | N/A 2025-08-20 | ATAI Life Sciences B.V. | ATAI | WEAVER GREGORY L Chief Financial Officer | 0 | $0 | 880,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 4:16 pm | N/A 2031-05-14 | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 2:06 pm | N/A 2030-05-15 | ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2020-03-15 Exercise | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L FORMER CHIEF FINANCIAL OFFICER | 3,750 | $0 | 10,431 (Direct) | View |
| 2020-03-15 Tax Withholding | 2020-03-16 4:10 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L FORMER CHIEF FINANCIAL OFFICER | 1,086 | $2.85 | 10,431 (Direct) | View |
| 2020-01-30 Exercise(A) | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 5,000 | $0 | 22,767 (Direct) | View |
| 2020-01-30 Tax Withholding(A) | 2020-03-04 2:30 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 1,733 | $3.91 | 22,767 (Direct) | View |
| 2020-01-30 Exercise | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 5,000 | $0 | 22,767 (Direct) | View |
| 2020-01-30 Tax Withholding | 2020-01-31 5:26 pm | N/A N/A | Eloxx Pharmaceuticals Inc. | ELOX | WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 1,733 | $3.91 | 22,767 (Direct) | View |